Anti-TNF, Infliximab, and Adalimumab can be effective in eosinophilic bowel disease

Translated title of the contribution: Anti-TNF, Infliximab, and Adalimumab can be effective in eosinophilic bowel disease

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Anti-TNF, Infliximab, and Adalimumab can be effective in eosinophilic bowel disease
Original language	Undefined/Unknown
Pages (from-to)	492-497
Number of pages	6
Journal	Journal of Pediatric Gastroenterology and Nutrition
Volume	56
Issue number	5
DOIs	https://doi.org/10.1097/MPG.0b013e3182801e60
Publication status	Published - 2013

Access to Document

@article{7f59708c0f044f70bb55e45beac7e202,

title = "Anti-TNF, Infliximab, and Adalimumab can be effective in eosinophilic bowel disease",

author = "D. Turner and V.M. Wolters and R.K. Russell and V. Shakhnovich and A.M. Muise and O. Ledder and B. Ngan and C. Friesen",

year = "2013",

doi = "10.1097/MPG.0b013e3182801e60",

language = "Undefined/Unknown",

volume = "56",

pages = "492--497",

journal = "Journal of Pediatric Gastroenterology and Nutrition",

issn = "0277-2116",

publisher = "John Wiley \& Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Anti-TNF, Infliximab, and Adalimumab can be effective in eosinophilic bowel disease

AU - Turner, D.

AU - Wolters, V.M.

AU - Russell, R.K.

AU - Shakhnovich, V.

AU - Muise, A.M.

AU - Ledder, O.

AU - Ngan, B.

AU - Friesen, C.

PY - 2013

Y1 - 2013

U2 - 10.1097/MPG.0b013e3182801e60

DO - 10.1097/MPG.0b013e3182801e60

M3 - Article

C2 - 23221994

SN - 0277-2116

VL - 56

SP - 492

EP - 497

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

IS - 5

ER -